Cloning techniques produce FDA-approved antibiotic

A study published in Chemistry and Biology by Huimin Zhao, associate professor of chemical and biomolecular engineering and affiliate of the Center for Biophysics and Computational Biology and Wilfred A. van der Donk, professor of chemistry and affiliate of the Department of Biochemistry, concludes that fosfomycin, a phosphoric acid compound, provides researchers and clinicians with the potential for developing new treatments for bacterial infections.

News Bureau article

November 27, 2006 All News